0 Commentaires
0 Parts
536 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Anaplastic Large Cell Lymphoma Therapeutics Market – Targeted Oncology Treatments Advancing Rare Lymphoma CareMarket Overview The anaplastic large cell lymphoma therapeutics market is advancing as targeted oncology treatments improve outcomes for this rare, aggressive form of non-Hodgkin lymphoma. Anaplastic large cell lymphoma therapeutics have evolved significantly with the introduction of antibody-drug conjugates and targeted small-molecule inhibitors that address the disease's characteristic...0 Commentaires 0 Parts 178 Vue 0 Aperçu
-
Dermatologic Oncology: Market Trends in Skin Cancer TherapeuticsDermatologic oncology is at the forefront of the fight against skin cancer, a field that has witnessed remarkable progress in recent decades. Dermatologic oncology now encompasses a comprehensive approach to skin cancer management, integrating surgical expertise with cutting-edge medical therapies for conditions like basal cell carcinoma (BCC). The global market for BCC treatments is...0 Commentaires 0 Parts 300 Vue 0 Aperçu
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Commentaires 0 Parts 828 Vue 0 Aperçu
-
Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market Report: Precision Oncology and Drug Pipeline Trends"According to the latest report published by Data Bridge Market Research, the Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market The expected CAGR of mitogen-activated protein kinase (MAPK) inhibitors therapeutics market is tend to be around 6.60% in the mentioned forecast period. The market is valued at USD 61.4 billion in 2022, and it would grow upto USD...0 Commentaires 0 Parts 266 Vue 0 Aperçu
-
Natural Killer (NK) Cell Therapeutics Market Size and Oncology Trends 2033The oncology landscape is shifting toward more sophisticated, "off-the-shelf" cellular interventions that leverage the body’s innate immune system. The Natural Killer (NK) Cell Therapeutics Market was valued at USD 504.09 million in 2024 and is projected to skyrocket to USD 9,839.77 million by 2032, growing at an extraordinary CAGR of 109.97% during the...0 Commentaires 0 Parts 433 Vue 0 Aperçu
-
Oncology Immuno Drug Market – Immune-Based Therapeutics Reshaping Cancer Treatment ParadigmsMarket Overview The oncology immuno drug market is expanding rapidly as immune-based therapeutics reshape cancer treatment paradigms across a growing range of tumor types. Immuno-oncology drugs, including checkpoint inhibitors and cell-based therapies, harness the body's own immune system to identify and eliminate cancer cells, offering durable responses that have transformed outcomes for...0 Commentaires 0 Parts 218 Vue 0 Aperçu
-
Peot Cancer Therapeutics Market Trends Shaping the Future of Veterinary Oncology TreatmentsThe Pet Cancer Therapeutics Market is witnessing significant global growth due to the rising prevalence of cancer in companion animals, increasing pet humanization, and advancements in veterinary oncology treatments. As pets live longer due to improved nutrition and healthcare, the incidence of age-related diseases such as cancer has increased, driving demand for advanced therapeutic solutions....0 Commentaires 0 Parts 287 Vue 0 Aperçu
-
Targeted Cancer Therapeutics: The NRG1 Fusion Market and Precision Oncology InnovationsTargeted cancer therapeutics represent the forefront of oncology, offering precise and effective treatment options for patients with genetically defined cancers. Among the most promising targets are NRG1 fusions, rare genetic alterations found in a small but significant subset of solid tumors. The targeted cancer therapeutics market is experiencing substantial growth, with projections...0 Commentaires 0 Parts 258 Vue 0 Aperçu
-
Dasatinib Market Growth in Emerging Healthcare MarketsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Anal Cancer Market Size Projected to Reach USD 978.10 Million by 2032“According to a new report published by Introspective Market Research, Anal Cancer Market by Cancer Type, Treatment Type, and End User, The Global Anal Cancer Market Size Was Valued at USD 638.11 Million in 2023 and is Projected to Reach USD 978.10 Million by 2032, Growing at a CAGR of 4.86% From 2024–2032.” The Anal Cancer Market is witnessing steady growth due to rising...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Anti-Emetic Drugs Market Size, Share, and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030. “D2 Receptors”...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Commentaires 0 Parts 12KB Vue 0 Aperçu
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Commentaires 0 Parts 9KB Vue 0 Aperçu
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Commentaires 0 Parts 11KB Vue 0 Aperçu
-
Cytotoxic Drugs Market Size, Share, Trends & Forecast to 2032According to the latest report published by Data Bridge Market Research, the Cytotoxic Drugs Market Global cytotoxic drugs market size was valued at USD 17.59 billion in 2024 and is projected to reach USD 42.11 billion by 2032, with a CAGR of 7.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate,...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali